333 related articles for article (PubMed ID: 35817212)
1. HuR as a molecular target for cancer therapeutics and immune-related disorders.
Majumder M; Chakraborty P; Mohan S; Mehrotra S; Palanisamy V
Adv Drug Deliv Rev; 2022 Sep; 188():114442. PubMed ID: 35817212
[TBL] [Abstract][Full Text] [Related]
2. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.
Wang J; Guo Y; Chu H; Guan Y; Bi J; Wang B
Int J Mol Sci; 2013 May; 14(5):10015-41. PubMed ID: 23665903
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of TTP and HuR plays an important role in cancers.
Wang H; Ding N; Guo J; Xia J; Ruan Y
Tumour Biol; 2016 Nov; 37(11):14451-14461. PubMed ID: 27644249
[TBL] [Abstract][Full Text] [Related]
4. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
[TBL] [Abstract][Full Text] [Related]
6. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.
Calaluce R; Gubin MM; Davis JW; Magee JD; Chen J; Kuwano Y; Gorospe M; Atasoy U
BMC Cancer; 2010 Apr; 10():126. PubMed ID: 20370918
[TBL] [Abstract][Full Text] [Related]
7. Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).
Schultz CW; Preet R; Dhir T; Dixon DA; Brody JR
Wiley Interdiscip Rev RNA; 2020 May; 11(3):e1581. PubMed ID: 31970930
[TBL] [Abstract][Full Text] [Related]
8. Targeting the RNA-Binding Protein HuR in Cancer.
Finan JM; Sutton TL; Dixon DA; Brody JR
Cancer Res; 2023 Nov; 83(21):3507-3516. PubMed ID: 37683260
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
Gubin MM; Calaluce R; Davis JW; Magee JD; Strouse CS; Shaw DP; Ma L; Brown A; Hoffman T; Rold TL; Atasoy U
Cell Cycle; 2010 Aug; 9(16):3337-46. PubMed ID: 20724828
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein HuR in human cancer: A friend or foe?
Wu X; Xu L
Adv Drug Deliv Rev; 2022 May; 184():114179. PubMed ID: 35248670
[TBL] [Abstract][Full Text] [Related]
11. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.
Kim Y; Noren Hooten N; Dluzen DF; Martindale JL; Gorospe M; Evans MK
Mol Cell Biol; 2015 Dec; 35(24):4212-21. PubMed ID: 26438598
[TBL] [Abstract][Full Text] [Related]
13. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium.
Fan J; Ishmael FT; Fang X; Myers A; Cheadle C; Huang SK; Atasoy U; Gorospe M; Stellato C
J Immunol; 2011 Feb; 186(4):2482-94. PubMed ID: 21220697
[TBL] [Abstract][Full Text] [Related]
14. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
[No Abstract] [Full Text] [Related]
16. Posttranslational control of HuR function.
Grammatikakis I; Abdelmohsen K; Gorospe M
Wiley Interdiscip Rev RNA; 2017 Jan; 8(1):. PubMed ID: 27307117
[TBL] [Abstract][Full Text] [Related]
17. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of HuR in inflammatory response in kidney diseases.
Shang J; Zhao Z
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):753-763. PubMed ID: 28910975
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.
Shi J; He Y; Hewett SJ; Hewett JA
J Biol Chem; 2016 Jan; 291(4):1643-1651. PubMed ID: 26601945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
